Orbimed Advisors LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Orbimed Advisors LLC

  • $4.15 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $5.06 Million - $6.38 Million
-75,000 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $14.1 Million - $16.4 Million
-175,000 Reduced 70.0%
75,000 $6.42 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $21.1 Million - $24.7 Million
250,000 New
250,000 $22.2 Million

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email